<div id="readability-page-1"><p>Shares of Plexus Corp. (NASDAQ:PLXS - Get Free Report) have been assigned an average rating of &#34;Moderate Buy&#34; from the six research firms that are currently  covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating, three have issued  a buy rating and one  has assigned  a strong buy rating to  the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $194.20.</p><ul><li>This mid-cap tech stock just jumped 30%...and is still cheap</li></ul><p>Several analysts have recently weighed in on the stock. Zacks Research upgraded shares of Plexus from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, February 6th. Wall Street Zen cut Plexus from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Sunday, March 8th. Williams Trading  set a $195.00 price target on Plexus in a research report on Wednesday, January 28th. Needham &amp; Company LLC lifted their price target on Plexus from $165.00 to $206.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, January 30th. Finally, Benchmark  reiterated a &#34;buy&#34; rating and issued a $220.00 price objective on shares of Plexus in a report on Monday, March 16th.</p><p><b>Check Out Our Latest Analysis on PLXS</b></p><h2>Plexus Stock Performance</h2><p>Shares of PLXS opened at $202.54 on Wednesday. Plexus has a 12-month low of $103.43 and a 12-month high of $220.17. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The company has a market cap of $5.43 billion, a PE ratio of 31.50 and a beta of 0.81. The stock has a 50-day moving average price of $196.39 and a 200-day moving average price of $165.55. </p><p>Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.07 billion. During the same period in the prior year, the business earned $1.73 earnings per share. Plexus's revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.  As a group, equities analysts forecast that  Plexus will post 5.9 earnings per share for the current fiscal year. </p><h2>Insider Buying and Selling</h2><p>In other Plexus news, CFO Patrick John Jermain sold 2,321 shares of the business's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $201.12, for a total value of $466,799.52. Following the completion of the sale, the chief financial officer directly owned 14,561 shares of the company's stock, valued at $2,928,508.32. The trade was a 13.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Oliver K. Mihm sold 9,541 shares of the company's stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the sale, the chief operating officer owned 12,809 shares of the company's stock, valued at approximately $2,579,732.60. The trade was a 42.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 49,495 shares of company stock worth $10,009,836 over the last ninety days. Corporate insiders own  1.78% of the company's stock. </p><h2>Institutional Investors Weigh In On Plexus</h2><p>Hedge funds and other institutional investors have recently modified their holdings of the stock. Inspire Investing LLC boosted its holdings in  Plexus by 1.6% in the 4th quarter. Inspire Investing LLC now owns 3,178 shares of the technology company's stock worth $467,000 after buying an additional 50 shares during the period.  Allworth Financial LP raised its holdings in  Plexus by 20.8% during the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company's stock valued at $44,000 after acquiring an additional 52 shares during the period.  Maryland State Retirement &amp; Pension System lifted its position in shares of  Plexus by 1.5% in the fourth quarter. Maryland State Retirement &amp; Pension System now owns 3,940 shares of the technology company's stock valued at $579,000 after acquiring an additional 60 shares in the last quarter.  Oregon Public Employees Retirement Fund boosted its stake in shares of  Plexus by 1.2% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company's stock worth $908,000 after acquiring an additional 71 shares during the period.  Finally, Uncommon Cents Investing LLC boosted its stake in shares of  Plexus by 0.8% in the fourth quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company's stock worth $1,459,000 after acquiring an additional 75 shares during the period. Institutional investors own  94.45% of the company's stock. </p><h2>Plexus Company Profile</h2> (Get Free Report)<p>Plexus Corp. <span>NASDAQ: PLXS<span></span></span> is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.  </p><p>Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Plexus</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExYUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExYUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Plexus Right Now?</h2><p>Before you consider Plexus, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.</p><p>While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

PLXS

<p>Plexus Corp. (NASDAQ:PLXS) has received a consensus rating of "Moderate Buy" from six research firms. Analysts' ratings include two holds, three buys, and one strong buy, with an average 12-month price target of $194.20. The stock recently surged 30%, opening at $202.54. Plexus reported $1.78 EPS for the last quarter, exceeding estimates, and anticipates 5.9 EPS for the current fiscal year. Insider selling has occurred, with CFO and COO reducing their stakes. Institutional investors have also adjusted their holdings in the company.</p>

Plexus Corp. (NASDAQ:PLXS) Given Consensus Rating of "Moderate Buy" by Analysts